The effect of selenium supplementation on sonographic findings of salivary glands in papillary thyroid cancer (PTC) patients treated with radioactive iodine: study protocol for a double-blind, randomized, placebo-controlled clinical trial
DiscussionDue to its anti-inflammatory and antioxidant effects, as well as improving salivary secretions, selenium may improve the symptoms of thyroid cancer treated with radioactive iodine. In past studies, selenium consumption has not reduced the therapeutic effects of radiation therapy, and at a dose of 300 to 500 μg/day, it has not had any significant side effects in many types of cancer under radiation therapy.Trial registrationIranian Registry of Clinical TrialsIRCT20201129049534N6. Registered on 16 September 2021. (Source: Trials)
Source: Trials - August 7, 2023 Category: Research Source Type: clinical trials
Strawberry Consumption May Improve Cognitive Function in Older Adults, New Study Says
BOSTON, July 24, 2023. Daily strawberry consumption was linked to improved cognitive function, lower blood pressure and higher antioxidant capacity in a randomized clinical trial presented today at Nutrition 2023, the annual meeting of the American... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - July 24, 2023 Category: Pharmaceuticals Source Type: clinical trials
The impact of a blend of Pistacia atlantica seed and canola oil compared with a blend of corn-canola oil with synthetic antioxidant and corn-canola oil without synthetic antioxidant on oxidative stress markers in patients with metabolic syndrome: protocol for a triple-blind, randomized, three-way cross-over clinical trial
DiscussionPistacia atlantica seed oil is high in antioxidants. An intervention with this oil could offer an option for oxidative stress prevention among patients with metabolic syndrome. The present clinical trial will be the first one assessing the impact ofPistacia atlantica oil on human oxidative stress markers.Trial registrationIranian Registry of Clinical trialsIRCT20130223012571N8. Registered on 4 March 2022. (Source: Trials)
Source: Trials - July 24, 2023 Category: Research Source Type: clinical trials
Vestibular Function Using Mitochondrial Antioxidant Therapy
Condition: Vestibular Function Disorder Interventions: Drug: Alpha Lipoic Acid 300mg; Drug: Coenzyme Q10 200mg Sponsors: The University of Texas Health Science Center at San Antonio; National Institute on Aging (NIA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2023 Category: Research Source Type: clinical trials
